Healthcare Sales & Marketing Network News: LOTEMAX

Searching News Database: LOTEMAX

HSMN NewsFeed - 2 Apr 2019
Bausch & Lomb Announces the U.S. Launch of LOTEMAX(R) SM (Loteprednol Etabonate Ophthalmic Gel) 0.38% for the Treatment of Postoperative Inflammation and Pain Following Ocular Surgery
Biopharmaceuticals Ophthalmology Surgery Product Launch

HSMN NewsFeed - 6 Aug 2013
Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch & Lomb
Biopharmaceuticals Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 3 Mar 2009
Pfizer and Bausch & Lomb to Co-Promote Products for the Treatment of Ophthalmic Conditions
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 18 Sep 2006
Bausch & Lomb Licenses SEGRA Compound From Schering AG for Ophthalmic Use
Biopharmaceuticals Licensing Ophthalmology

Return to NewsFeed

Additional items found! 1

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 1 additional stories matching:
LOTEMAX
(Password required)

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!